Cluster Headache Trends
- Cluster headache affects approximately 0.1% of the population (~124 per 100,000 individuals), classified as a rare disease meeting FDA/EMA rarity criteria
- Historically shows 3:1 male-to-female ratio, but recent studies indicate the gender gap is narrowing Peak age of onset is around 30 years, though it can develop at any age
- Only 3.5–13.7% of patients develop chronic cluster headache; the majority have episodic form.
- First-degree family members are 18 times more likely to be diagnosed, suggesting a genetic component.
Cluster Headache Market Size and Forecast in the 7MM
- 2025 Cluster Headache Diganosed Prevalent Cases: ~XX Cases
- Cluster Headache Growth Rate (2026–2036): XX% CAGR
DelveInsight's ‘Cluster Headache Market Insights, Epidemiology and Market Forecast – 2036’ report delivers an in-depth understanding of the cluster headache, historical and forecasted epidemiology, as well as the cluster headache market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.
The Cluster Headache market report delivers a comprehensive analysis of the current treatment landscape, including standards of care, clinical practices, and evolving therapeutic algorithms. It evaluates, cluster headache patient burden trends, revenue & market share dynamics, peak patient share & therapy uptake analysis, and provides an in-depth market size assessment, and growth rate projections (Historical & Forecast 2022–2036) across global regions. The report highlights key unmet medical needs in cluster headache and maps the competitive and clinical landscape to uncover high‑value opportunities, providing a clear outlook on future market growth potential.
|
Study Period
|
2022–2036
|
|
Historical Year
|
2022–2025
|
|
Forecast Period
|
2026–2036
|
|
Base Year
|
2026
|
|
Geographies Covered
|
|
|
cluster headache Market CAGR
(Forecast period)
|
XX% (2026–2036)
|
Cluster Headache Understanding
Cluster Headache Overview
Cluster headache is a severe neurological disorder characterized by recurrent attacks of intense unilateral head pain, typically centered around the eye or temple, and often accompanied by autonomic symptoms such as tearing, nasal congestion, eyelid swelling, facial sweating, and restlessness. Attacks usually occur in clusters over weeks or months, followed by remission periods, although some patients experience chronic forms without significant remission. The exact cause remains unclear, but hypothalamic dysfunction, trigeminal nerve activation, genetic predisposition, smoking, and alcohol consumption are considered important contributing factors. Diagnosis is primarily based on clinical presentation and headache patterns, supported by neuroimaging to exclude secondary causes. Current treatment focuses on rapid symptom relief with oxygen therapy and triptans for acute attacks, while preventive therapies such as verapamil, corticosteroids, lithium, and CGRP-targeting agents are used to reduce attack frequency and severity.
Diagnosis of Cluster headache is primarily based on clinical evaluation, characteristic headache patterns, and associated autonomic symptoms. Patients typically present with severe unilateral orbital, supraorbital, or temporal pain accompanied by symptoms such as lacrimation, nasal congestion, conjunctival injection, eyelid edema, facial sweating, or restlessness occurring in recurrent cluster periods. Diagnosis is guided by established clinical criteria and detailed patient history, while neuroimaging techniques such as MRI or CT scans are often performed to exclude secondary neurological or structural causes. Additional assessments may also be used to differentiate cluster headache from migraine, trigeminal neuralgia, and other primary headache disorders.
Further details are provided in the report.
Cluster Headache Epidemiology
Key Findings from cluster headache Epidemiological Analysis and Forecast
- Cluster headache can develop at any age, although onset most commonly occurs around 30 years of age. The condition is more prevalent in men than women, with men historically affected about three times more often, though recent studies suggest this gender gap has narrowed over time.
- According to DelveInsight’s analysis in 2025, the total prevalent cases of cluster headache accounted for nearly 890,000 in the 7MM. The highest number of cases was seen in the US. These cases are expected to increase by 2036 at a significant CAGR.
- There were approximately 144,000 males and nearly 62,000 females affected by Cluster headache in the United States in 2025, and it is estimated that the gender-specific diagnosed prevalent cases of cluster headache will increase in the forecast period.
- As per estimates based on DelveInsight’s epidemiology model for Cluster Headache, Japan had about 152,500 prevalent cases of Cluster headache in 2025. These cases are anticipated to decrease by 2036.
Scope of the Report
- The report covers a segment of key events, an executive summary, a descriptive overview of Cluster Headache, explaining their causes, signs and symptoms, and pathogenesis.
- Comprehensive insight has been provided into the epidemiology segments and forecasts, the future growth potential of the diagnosis rate, and disease progression.
Report Insights
Cluster Headache Patient Population Forecast
Report Key Strengths
- Epidemiology‑based (Epi‑based) Bottom‑up Forecasting
- 11-Year Forecast
- Patient Burden Trends (By Geography)
FAQs
- What are the disease risks, burdens, and unmet needs of Cluster Headache? What will be the growth opportunities across the 7MM concerning the patient population with Cluster Headache?
- What is the historical and forecasted Cluster Headache patient pool in the US, EU4 (Germany, France, Italy, and Spain), the UK, and Japan?
Reasons to Buy
- Insights on patient burden/disease prevalence, evolution in diagnosis, and factors contributing to the change in the epidemiology of the disease during the forecast years.
- To understand key opinion leaders’ perspectives around the diagnostic challenges to overcome barriers in the future.
- Detailed insights on various factors hampering disease diagnosis and other existing diagnostic challenges.
1. Key Insights
2. Report Introduction
3. Executive Summary of Cluster Headache
4. Epidemiology Methodology of Cluster Headache
5. Cluster Headache Epidemiology Overview at a Glance
5.1 Patient Share of Cluster Headache (%) in the 7MM in 2025
5.2 Patient Share of Cluster Headache (%) in the 7MM in 2036
6. Disease Background and Overview of Cluster Headache
6.1 Introduction
6.2 Signs and Symptoms
6.3 Stages and Clinical Presentation of Cluster Headache
6.4 Causes
6.5 Pathogenesis
6.6 Diagnosis
6.6.1 Diagnostic Algorithm
6.6.2 Diagnostic Approach
6.6.3 Diagnostic Recommendations
6.7 Differential Diagnosis
7. Epidemiology and Patient Population of Cluster Headache
7.1 Key Findings
7.2 Assumptions and Rationale: The 7MM
7.2.1 Total Incident Cases of Cluster Headache in the 7MM
7.2.2 Treated Cases of Cluster Headache in the 7MM
7.3 The United States
7.3.1 Total Prevalent Cases of Cluster Headache in the United States
7.3.2 Diagnosed Prevalent Cases of Cluster Headache in the United States
7.3.3 Type-specific Diagnosed Prevalent Cases of Cluster Headache in the United States
7.3.4 Gender-specific Diagnosed Prevalent Cases of Cluster Headache in the United States
7.3.5 Age-specific Diagnosed Prevalent Cases of Cluster Headache in the United States
7.3.6 Treated Cases of Cluster Headache in the United States
7.4 EU4 and the United Kingdom
7.4.1 Total Prevalent Cases of Cluster Headache in EU4 and the United Kingdom
7.4.2 Diagnosed Prevalent Cases of Cluster Headache in EU4 and the United Kingdom
7.4.3 Type-specific Diagnosed Prevalent Cases of Cluster Headache in EU4 and the United Kingdom
7.4.4 Gender-specific Diagnosed Prevalent Cases of Cluster Headache in EU4 and the United Kingdom
7.4.5 Age-specific Diagnosed Prevalent Cases of Cluster Headache in EU4 and the United Kingdom
7.4.6 Treated Cases of Cluster Headache in EU4 and the United Kingdom
7.5 Japan
7.5.1 Total Prevalent Cases of Cluster Headache in Japan
7.5.2 Diagnosed Prevalent Cases of Cluster Headache in Japan
7.5.3 Type-specific Diagnosed Prevalent Cases of Cluster Headache in Japan
7.5.4 Gender-specific Diagnosed Prevalent Cases of Cluster Headache in Japan
7.5.5 Age-specific Diagnosed Prevalent Cases of Cluster Headache in Japan
7.5.6 Treated Cases of Cluster Headache in Japan
8. Appendix
8.1 Bibliography
8.2 Report Methodology
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
List of Tables:
List of Table
Table 1: Summary of Cluster Headache, Market, Epidemiology, and Key Events (2021-2034)
Table 2: Difference between Cluster Headache and Migraine
Table 3: Characteristics of cluster headache and other headache types that can have overlapping features
Table 4: Recommendations AHS made for the treatment of CH made according to AAN grades for classification
Table 5: Efficacy, Adverse Events, Level of Evidence and Recommendations for the Acute Therapy of Cluster Headache
Table 6: Efficacy, Adverse Events, Level of Evidence and Recommendations for the Therapy of Cluster Headache
Table 7: Diagnosed Incident Population of Cluster Headache in 7MM (2021-2034)
Table 8: Prevalence of Cluster Headache in the United States (2021-2034)
Table 9: Diagnosed cases of Cluster Headache in the United States (2021-2034)
Table 10: Type-specific cases of Cluster Headache in the United States (2021-2034)
Table 11: Gender-specific cases of Cluster Headache in the United States (2021-2034)
Table 12: Age-specific cases of Cluster Headache in the United States (2021-2034)
Table 13: Prevalence of Cluster Headache in Germany (2021-2034)
Table 14: Diagnosed cases of Cluster Headache in Germany (2021-2034)
Table 15: Type-specific cases of Cluster Headache in Germany (2021-2034)
Table 16: Gender-specific cases of Cluster Headache in Germany (2021-2034)
Table 17: Age-specific Cases of Cluster Headache in Germany (2021-2034)
Table 18: Prevalence of Cluster Headache in France (2021-2034)
Table 19: Diagnosed of Cluster Headache in France (2021-2034)
Table 20: Type-specific cases of Cluster Headache in France (2021-2034)
Table 21: Gender-specific cases of Cluster Headache in France (2021-2034)
Table 22: Age-specific Cases of Cluster Headache in France (2021-2034)
Table 23: Prevalence of Cluster Headache in Italy (2021-2034)
Table 24: Diagnosed of Cluster Headache in Italy (2021-2034)
Table 25: Type-specific cases of Cluster Headache in Italy (2021-2034)
Table 26: Gender-specific cases of Cluster Headache in Italy (2021-2034)
Table 27: Age-specific Cases of Cluster Headache in Italy (2021-2034)
Table 28: Prevalence of Cluster Headache in Spain (2021-2034)
Table 29: Diagnosed of Cluster Headache in Spain (2021-2034)
Table 30: Type-specific cases of Cluster Headache in Spain (2021-2034)
Table 31: Gender-specific cases of Cluster Headache in Spain (2021-2034)
Table 32: Age-specific Cases of Cluster Headache in Spain (2021-2034)
Table 33: Prevalence of Cluster Headache in the United Kingdom (2021-2034)
Table 34: Diagnosed of Cluster Headache in the UK (2021-2034)
Table 35: Type-specific cases of Cluster Headache in the UK (2021-2034)
Table 36: Gender-specific cases of Cluster Headache in the United Kingdom (2021-2034)
Table 37: Age-specific Cases of Cluster Headache in the United Kingdom (2021-2034)
Table 38: Prevalence of Cluster Headache in Japan (2021-2034)
Table 39: Diagnosed cases of Cluster Headache in Japan (2021-2034)
Table 40: Type-specific cases of Cluster Headache in Japan (2021-2034)
Table 41: Gender-specific cases of Cluster Headache in Japan (2021-2034)
Table 42: Age-specific Cases of Cluster Headache in Japan (2021-2034)
List of Figures:
List of Figures
Figure 1: Hypothetical pathophysiological model of cluster headache
Figure 2: Anatomical and neurotransmitter components of cluster headache pathophysiology
Figure 3: Cluster headache diagnostic criteria (adapted from International Classification of Headache Disorders, Third Edition)
Figure 4: Diagnostic Algorithm for Cluster Headache
Figure 5: Diagnosed Incident Population of Cluster Headache in 7MM (2021-2034)
Figure 6: Prevalence of Cluster Headache in the United States (2021-2034)
Figure 7: Diagnosed cases of Cluster Headache in the United States (2021-2034)
Figure 8: Type-specific cases of Cluster Headache in the United States (2021-2034)
Figure 9: Gender-specific cases of Cluster Headache in the United States (2021-2034)
Figure 10: Age-specific cases of Cluster Headache in the United States (2021-2034)
Figure 11: Prevalence of Cluster Headache in Germany (2021-2034)
Figure 12: Diagnosed cases of Cluster Headache in Germany (2021-2034)
Figure 13: Type-specific cases of Cluster Headache in Germany (2021-2034)
Figure 14: Gender-specific cases of Cluster Headache in Germany (2021-2034)
Figure 15: Age-specific Cases of Cluster Headache in Germany (2021-2034)
Figure 16: Prevalence of Cluster Headache in France (2021-2034)
Figure 17: Diagnosed cases of Cluster Headache in France (2021-2034)
Figure 18: Type-specific cases of Cluster Headache in France (2021-2034)
Figure 19: Gender-specific cases of Cluster Headache in France (2021-2034)
Figure 20: Age-specific Cases of Cluster Headache in France (2021-2034)
Figure 21: Prevalence of Cluster Headache in Italy (2021-2034)
Figure 22: Diagnosed cases of Cluster Headache in Italy (2021-2034)
Figure 23: Type-specific cases of Cluster Headache in Italy (2021-2034)
Figure 24: Gender-specific cases of Cluster Headache in Italy (2021-2034)
Figure 25: Age-specific Cases of Cluster Headache in Italy (2021-2034)
Figure 26: Prevalence of Cluster Headache in Spain (2021-2034)
Figure 27: Diagnosed cases of Cluster Headache in Spain (2021-2034)
Figure 28: Type-specific cases of Cluster Headache in Spain (2021-2034)
Figure 29: Gender-specific cases of Cluster Headache in Spain (2021-2034)
Figure 30: Age-specific Cases of Cluster Headache in Spain (2021-2034)
Figure 31: Prevalence of Cluster Headache in the United Kingdom (2021-2034)
Figure 32: Diagnosed cases of Cluster Headache in the UK (2021-2034)
Figure 33: Type-specific cases of Cluster Headache in the UK (2021-2034)
Figure 34: Gender-specific cases of Cluster Headache in the United Kingdom (2021-2034)
Figure 35: Age-specific Cases of Cluster Headache in the United Kingdom (2021-2034)
Figure 36: Prevalence of Cluster Headache in Japan (2021-2034)
Figure 37: Diagnosed cases of Cluster Headache in Japan (2021-2034)
Figure 38: Type-specific cases of Cluster Headache in Japan (2021-2034)
Figure 39: Gender-specific cases of Cluster Headache in Japan (2021-2034)
Figure 40: Age-specific Cases of Cluster Headache in Japan (2021-2034)
